The L-0.9 mg 1-10 hydrogel formulation exhibited a C max of 620 110 ng/mL (observed on day 9), while the L-0.9 mg 2-10 hydrogel formulation exhibited a C max of 930 350 ng/mL (observed on day 20) with relatively steady plasma concentrations throughout the duration of the study (Figure 4D, Table S2)
Patient Education Priorities: Comprehensive patient education on proper injection technique, site rotation, storage requirements, recognition of potential adverse effects (especially gastrointestinal), and the importance of gradual dose escalation is essential for successful therapy
It rarely covers them for other non-diabetes indications
This will allow patients to use Him & Hers to, following physician consultation, access multiple FDA-approved doses and formulations
However, the Fssai recently approved the supplement and Imbms are now including this supplement on their labels
Final formulation, dosage, treatment duration and total cost are determined during consultation with a licensed healthcare provider